@EricTopol
In a randomized trial, the self-amplifying mRNA Covid vaccine approved in Japan as a booster induced higher levels of neutralizing antibodies than the @Pfizer
booster at 6 and 12 months vs multiple strains

thelancet.com
12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine
@TheLancetInfDis
画像
午前10:56 · 2024年10月8日

EU、新型コロナのレプリコンワクチン承認へ　開発元の米企業が申請
2024/12/16